Detected ·
Kanjin Therapeutics
$600K—
Kanjin Therapeutics, Inc., a kidney disease drug discovery startup, received an additional investment of US$600,000 from Kyoto University Innovation Capital (Kyoto-iCAP) to support nonclinical studies, formulation development, and R&D capabilities.
- Website
- www.kanjin-tx.com
- Amount
- $600 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-31 20:07:30 UTC
- Signal ID
- 0f64ffa6-0153-42e4-888c-37dffd2b4752
As the API returns it
{
"id": "0f64ffa6-0153-42e4-888c-37dffd2b4752",
"created_at": "2026-07-31T20:07:30.503668Z",
"company_name": "Kanjin Therapeutics",
"company_website_url": "www.kanjin-tx.com",
"company_linkedin_url": "https://www.linkedin.com/company/kanjin-therapeutics",
"event_type": "funding",
"funding_amount": 600000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Kanjin Therapeutics, Inc., a kidney disease drug discovery startup, received an additional investment of US$600,000 from Kyoto University Innovation Capital (Kyoto-iCAP) to support nonclinical studies, formulation development, and R&D capabilities.*"
}